UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 1-2189 ABBOTT LABORATORIES An Illinois Corporation I.R.S. Employer Identification No. 36-0698440 100 Abbott Park Road Abbott Park, Illin ...

Abbott Laboratories (NYSE:ABT) Q2 2023 Earnings Conference Call July 20, 2023 9:30 AM ET Company Participants Mike Comilla - Vice President, Investor Relations Robert Ford - Chairman and Chief Executive Officer Bob Funck - Executive Vice President, Finance and Chief Financial Officer Conference Call Participants Joshua Jennings - TD Cowen Larry Biegelsen - Wells Fargo Danielle Antalffy - UBS Vijay Kumar - Evercore ISI Joanne Wuensch - Citi Marie Thibault - BTIG Matt Miksic - Barclays Jayson Bedford - Raymon ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 1-2189 ABBOTT LABORATORIES An Illinois Corporation I.R.S. Employer Identification No. 36-0698440 100 Abbott Park Road Abbott Park, Illi ...

Abbott Laboratories (NYSE:ABT) Q1 2023 Earnings Conference Call April 19, 2023 9:00 AM ET Company Participants Scott Leinenweber - Vice President, Investor Relations Robert Ford - Chairman and Chief Executive Officer Bob Funck - Executive Vice President, Finance and Chief Financial Officer Conference Call Participants Larry Biegelsen - Wells Fargo Joshua Jennings - Cowen Robbie Marcus - JPMorgan Rick Wise - Stifel Vijay Kumar - Evercore ISI Joanne Wuensch - Citi Danielle Antalffy - UBS Matt Miksic - Barclay ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 ______________________________________________ FORM 10-K (MARK ONE) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 ________________________________________________________ For the fiscal year ended December 31, 2022 Commission file number 1-2189 Abbott Laboratories An Illinois Corporation 36-0698440 100 ...

Abbott Laboratories (NYSE:ABT) Q4 2022 Earnings Conference Call January 25, 2023 9:00 AM ET Company Participants Scott Leinenweber - Vice President, Investor Relations Robert Ford - Chairman and Chief Executive Officer Bob Funck - Executive Vice President, Finance and Chief Financial Officer Conference Call Participants Robbie Marcus - JPMorgan Larry Biegelsen - Wells Fargo Josh Jennings - Cowen Joanne Wuensch - Citibank Vijay Kumar - Evercore ISI Travis Steed - Bank of America Matt Miksic - Barclays Operat ...

Abbott Laboratories (NYSE:ABT) 41st Annual J.P. Morgan Healthcare Conference January 10, 2023 12:00 PM ET Company Participants Robert Ford - Chairman and Chief Executive Officer Conference Call Participants Robbie Marcus - J.P. Morgan Robbie Marcus Good morning, everyone. Welcome. I'm Robbie Marcus, medtech analyst at J.P. Morgan. Really happy to introduce our next session with Abbott Labs and the CEO Robert Ford. Robert, thanks for joining. Robert Ford Thanks for having us. Question-and-Answer Session Q - ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 1-2189 ABBOTT LABORATORIES An Illinois Corporation I.R.S. Employer Identification No. 36-0698440 100 Abbott Park ...

Abbott Laboratories (NYSE:ABT) Q3 2022 Earnings Conference Call October 19, 2022 9:00 AM ET Company Participants Scott Leinenweber - Vice President, Investor Relations, Licensing and Acquisition Robert Ford - Chairman and CEO Bob Funck - Executive Vice President, Finance and CFO Conference Call Participants Robbie Marcus - JPMorgan Larry Biegelsen - Wells Fargo Joanne Wuensch - Citibank Josh Jennings - Cowen Vijay Kumar - Evercore ISI Travis Steed - Bank of America Operator Good morning and thank you for st ...